AUG 08, 2017 03:27 PM PDT

A Common Chemo Drug Could Help Cancer Spread

WRITTEN BY: Xuan Pham
3 91 3660

Chemotherapy that’s intended to kill cancer could, in some disturbing twists of fate, help cancer metastasize. Alarmingly, a team of scientists recently found that the common chemotherapy drug paclitaxel may help breast cancer cells spread to the lungs in a rodent model.

Image credit: Pixabay.com

Paclitaxel (Taxol) was isolated in 1971 from the bark of the Pacific yew tree. The compound destroys cancer cells by interfering with the spindle microtubule mechanisms that allow correct alignment of the chromosomes during cell division. This interrupts the cell cycle and triggers apoptosis.  

In comparing the genetic profiles between patients who received paclitaxel versus those who had not, researchers noticed some differences. Specifically, the gene ATF3 seemed to be abundantly expressed in people who had been treated with chemotherapy. ATF3, a so-called “stress gene,” is a transcription factor that’s induced by stress signals and has been linked to many human diseases, including infections, atherosclerosis, and cancer. Some diseases associated with dysregulated ATF3 include colorectal cancer and bone cancer.

Researchers at Ohio State University found that paclitaxel seemed to set off a cascade of events involving ATF3, which may allow breast cancer cells to migrate from the primary tumor location.

"This gene [ATF3] seems to do two things at once: essentially help distribute the 'seeds' (cancer cells) and fertilize the 'soil' (the lung),” said Tsonwin Hai, a professor of biological chemistry and pharmacology at Ohio State University, and the study’s senior author.

"I think it's an active process -- a biological change in which the cancer cells are beckoned to escape into the blood -- rather than a passive process in which the cancer cells get into the bloodstream because of leaky vessels," Hai added.

After unwittingly helping open more doors for the cancer cells, paclitaxel may also create fertile grounds in other organs for the cancer cells to enter. "What is surprising to us is the multitude of pro-cancer effects that paclitaxel has! It not only enhances the escape of cancer cells from the primary tumor but also facilitates the preparation of distant sites (lung in our case) in such ways that when the cancer cells arrive, they can set up shop and grow,” said Hai.

On the other hand, there are mountains of evidence supporting the anticancer effects of paclitaxel. This common chemotherapy drug has been approved for a wide range of cancers, including ovarian, breast, lung, cervical, and pancreatic cancer. It’s also important to note that the current study analyzed breast cancer cells in a mouse model. Whether paclitaxel causes the same cascade of effects involving ATF3 in humans is not yet known.

"Therefore, at this point, we are not suggesting oncologists to change their clinical practices,” said Hai. Rather, “it is prudent to keep our mind open, realizing that chemo can help treat cancer, but at the same time may increase the possibility of the spread of that cancer.”

The researchers hope that through elucidating chemotherapy’s double-edged sword, we may one day be able to modify the drug to harness only its cancer-fighting properties.

Additional sources: Ohio State University, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 06, 2018
Cancer
APR 06, 2018
PanCancer Atlas of 33 Cancer Types for Genomic Profile Index Completed by NIH TCGA
The Cancer Genome Atlas project used genomic profiles and bioinformatics to catalogue 33 prevalent types of cancer and is available to the public after 10+ years of analysis.
APR 10, 2018
Clinical & Molecular DX
APR 10, 2018
New Biomarker Improves Combination Cancer Therapy
Two anti-cancer drugs are better than one, and the discovery of a new biomarker will likely help researchers identify the appropriate timing for the admini
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl
MAY 22, 2018
Cancer
MAY 22, 2018
Breakthrough Analysis Outlines Conceivable Cause of Childhood ALL
A team from the Institute of Cancer Research has published a comprehensive literature review and outlined a breakthrough in the causative theory of childhood ALL development.
JUN 05, 2018
Cancer
JUN 05, 2018
Precision vs. Personalized Medicine Part I: Precision Approach
So often the phrases "Precision Medicine" and "Personalized Medicine" are used interchangeably. Are they really synonyms? Part I looks at Precision Medicine
JUL 17, 2018
Cancer
JUL 17, 2018
Immunotherapy Diversification: From CAR-T cells to CAR-NK cells
New advances have made it possible for immunotherapy researchers to use natural killer cells, which are our body's normal defense for cancerous cells, to target tumors.
Loading Comments...